Previous Article | Next Article ![]()
Journal of Bacteriology, April 2001, p. 2367-2371, Vol. 183, No. 7
Infectious Disease Division and Medical
Services, Massachusetts General Hospital, Harvard Medical School,
Boston, Massachusetts 02114-2696
Received 29 November 2000/Accepted 17 January 2001
NorA, a multidrug efflux pump in Staphylococcus aureus,
protects the cell from multiple drugs, including quinolones. The
flqB mutation (T
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.7.2367-2371.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
A Mutation in the 5' Untranslated Region Increases
Stability of norA mRNA, Encoding a Multidrug Resistance
Transporter of Staphylococcus aureus

G) in the 5' untranslated region
upstream of norA causes norA overexpression of
4.9-fold in cis, as measured in norA::blaZ fusions. The
transcriptional initiation site of norA was unchanged in
mutant and wild-type strains, but the half-life of norA
mRNA was increased 4.8-fold in the flqB mutant compared to
the wild-type strain. Computer-generated folding of the first 68 nucleotides of the norA transcript predicts an additional
stem-loop and changes in a putative RNase III cleavage site in the
flqB mutant.
*
Corresponding author. Mailing address: Infectious
Disease Division, Massachusetts General Hospital, 55 Fruit Street,
Boston MA 02114-2696. Phone: (617) 726-3812. Fax: (617) 726-7416. E-mail: dhooper{at}partners.org.
Present address: Unité de Biochimie Microbienne, Institut
Pasteur, 75724 Paris Cedex 15, France.
This article has been cited by other articles:
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |